Infarct Size as Assessed by Peak Enzyme Levels is Reduced in Patients Who are Using Angiotensin-Converting Enzyme Inhibitors at the Onset of Infarction
作者： Knud Landmark , Ivar Aursnes
DOI: 10.2165/00044011-200020060-00004
关键词:
摘要: Objective: To investigate whether patients who are using angiotensin converting enzyme (ACE) inhibitors at the onset of infarction develop smaller infarcts, as assessed by peak levels, and to what extent this is associated with more non-Q-wave infarcts.
springer.com
sci-hub.se 参考文章(60)
W Westlin, K Mullane, Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation. ,vol. 77, ,(1988)
Effects of an angiotensin-converting -enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The New England Journal of Medicine. ,vol. 342, pp. 145- 153 ,(2000) , 10.1056/NEJM200001203420301
H Wesseling, van Wiekert Gilst, de Pieter Graeff, de Cees Langen, Jh Kingma, CONCENTRATION-DEPENDENT PROTECTION BY CAPTOPRIL AGAINST ISCHEMIA-REPERFUSION INJURY IN THE ISOLATED RAT-HEART Archives internationales de pharmacodynamie et de thérapie. ,vol. 280, pp. 181- 193 ,(1986)
P. Anversa, J. Wiener, F. Giacomelli, Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium. American Journal of Pathology. ,vol. 84, pp. 111- 138 ,(1976)
R Collins, R Peto, M Flather, S Parish, P Sleight, M Conway, A Pipilis, C Baigent, D Barnett, JP Boissel, A Budaj, J Cairns, L Ceremuzynski, AF Cohen, Gui De Backer, R Diaz, F Dienstl, P Dove, MG Franzosi, M Genoni, DA Halon, J Heikkila, C Hennekens, J Horgan, D Hunt, R Kala, N Karatzas, A Keech, M Keltai, J Kjekshus, M Kornitzer, R Koster, P Landless, P Lechleitner, A Leizorovicz, BS Lewis, L Lundkvist, S Macmahon, A Maggioni, R Malacrida, T Meyer, T Moccetti, D Ocallaghan, E Paolasso, LS Piegas, A Reikvam, P Ridker, T Ryan, R Schroder, R Seabragomes, JEMR Sousa, G Tognoni, A Turpie, V Valentin, J Varigos, H White, L Wilhelmsen, K Woods, S Yusuf, A Piombo, LA Guzman, DC Montenegro, G Irusta, RA Schneider, C Cuneo, BH Chamorro, GE Espinosa, M Moreno, MM Rios, R Doll, K Fox, D Julian, P Meier, E Sandoya, JE Perez, None, ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction. The Lancet. ,vol. 345, pp. 669- 685 ,(1995)
Infarct size as estimated from peak creatine kinase and lactate dehydrogenase is probably reduced in patients using calcium antagonists at the onset of symptoms. Cardiovascular Drugs and Therapy. ,vol. 11, pp. 557- 565 ,(1997) , 10.1023/A:1007727518684
R. Doğan, A. Sarigül, S. İsbir, B. Farsak, M. Tuncer, K. Kilinç, M. Demircin, Beneficial effect of captopril against ischaemia-reperfusion injury in isolated guinea pig hearts. Scandinavian Journal of Clinical & Laboratory Investigation. ,vol. 58, pp. 119- 126 ,(1998) , 10.1080/00365519850186698
GRUPPOITALIANOPERLOSTUDIODELL, GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction The Lancet. ,vol. 343, pp. 1115- 1122 ,(1994) , 10.1016/S0140-6736(94)90232-1
J. A. Madri, L. Bell, Influence of the angiotensin system on endothelial and smooth muscle cell migration. American Journal of Pathology. ,vol. 137, pp. 7- 12 ,(1990)
Robert A. Wright, Andrew D. Flapan, K.George M.M. Alberti, Christopher A. Ludlam, Keith A.A. Fox, Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction Journal of the American College of Cardiology. ,vol. 24, pp. 67- 73 ,(1994) , 10.1016/0735-1097(94)90543-6